Sign In
Buy ENDV
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
09:03am, Thursday, 28'th Mar 2024
Los Angeles, CA, March 28, 2024 (GLOBE NEWSWIRE) -- Endonovo (OTC PINK: ENDV) and its subsidiary, SofPulse, Inc., today announced they have finalized and completed the Asset Purchase Agreement (APA),
Endonovo's SofPulse® to Be Featured at Innovative Pain Management Solutions
09:09am, Monday, 04'th Mar 2024
US Army Medical Research and Development Command Vendor Day Los Angeles, CA, March 04, 2024 (GLOBE NEWSWIRE) -- SofPulse Inc. -- a subsidiary of Endonovo (OTC PINK: ENDV) and a proposed spin-off compa
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
09:15am, Monday, 04'th Dec 2023
Los Angeles, CA, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a commercial-stage developer of wearable products for pain relief, general wellness, and wound curatives m
Endonovo's SofPulse® Secures Taiwan FDA Approval
09:07am, Thursday, 12'th Oct 2023
Los Angeles, CA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product, SofP
Endonovo's SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
09:07am, Tuesday, 22'nd Aug 2023
Los Angeles, CA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a US-based commercial medical device company -- today announced its inclusion on the Federal Supply Sche
Endonovo's Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
09:03am, Tuesday, 08'th Aug 2023
Los Angeles, CA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) -- commercial developer of medical technology-- is proud to announce a series of advancements in the first h
Endonovo Therapeutics (OTCMKTS:ENDV) Stock Passes Below 50 Day Moving Average of $0.02
07:10am, Saturday, 27'th Nov 2021 Transcript Daily
Endonovo Therapeutics, Inc. (OTCMKTS:ENDV)s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.02 and traded as low as $0.02. Endonovo Therapeutics shares last traded at $0.02, with a volume of 30,013 shares traded. The companys 50-day simple moving average is []
Endonovo Therapeutics (OTCMKTS:ENDVD) Stock Price Down 4.6%
02:06pm, Thursday, 18'th Nov 2021 Dakota Financial News
Endonovo Therapeutics, Inc. (OTCMKTS:ENDVD)s stock price traded down 4.6% on Tuesday . The stock traded as low as $1.21 and last traded at $1.24. 11,000 shares changed hands during mid-day trading, a decline of 7% from the average session volume of 11,850 shares. The stock had previously closed at $1.30. The companys 50 day simple []
